Recent publications

Publications can be found through the individual profile pages of the division's staff members.

View the complete overview of the publications in PubMed.

Most recent publications

2024

Schouten, W. M., Roseboom, I. C., Lucas, L., Kabalu Tshiongo, J., Muhindo Mavoko, H., Kayentao, K., Rosing, H., Huitema, A. D. R., Beijnen, J. H., & Dorlo, T. P. C. (2024). Development and validation of an ultra-performance liquid chromatography-tandem mass spectrometry method for the quantification of the antimalarial drug pyronaridine in human whole blood. Journal of Pharmaceutical and Biomedical Analysis, 245, Article 116154. https://doi.org/10.1016/j.jpba.2024.116154
Joosse, I. R. (2024). Forging new paths in access to medicines research: Towards equitable access for all. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/2303
Pichler, F. B., Boysen, M., Mittmann, N., Gilardino, R., Bruce, A., Bond, K., Vreman, R. A., Largeron, N., Banhazi, J., Ollendorf, D. A., Jain, M., Upadhyaya, S., & Goettsch, W. G. (Accepted/In press). An operationalization framework for lifecycle HTA. International Journal of Technology Assessment in Health Care, 1-29. https://doi.org/10.1017/S0266462324000199
Meijvis, V. A. M. (2024). The CombiConsultation: Patient-centred pharmaceutical care by interprofessional collaboration. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/2200
Arnoldy, L., Gauci, S., Lassemillante, A.-C. M., Verster, J. C., Macpherson, H., Minihane, A.-M., Scholey, A., Pipingas, A., & White, D. J. (2024). Towards Consistency in Dietary Pattern Scoring: Standardising Scoring Workflows for Mediterranean, DASH, and MIND Diets Using 24-Hour Recall and Two Variations of a Food Frequency Questionnaire. British Journal of Nutrition, 131(9), 1554-1577. https://doi.org/10.1017/S0007114524000072
Rijmers, J., Retmana, I. A., Bui, V., Arguedas, D., Lebre, M. C., Sparidans, R. W., Beijnen, J. H., & Schinkel, A. H. (2024). ABCB1 attenuates brain exposure to the KRASG12C inhibitor opnurasib whereas binding to mouse carboxylesterase 1c influences its plasma exposure. Biomedicine and Pharmacotherapy, 175, Article 116720. Advance online publication. https://doi.org/10.1016/j.biopha.2024.116720
Pichler, F. B., Boysen, M., Mittmann, N., Gilardino, R., Bruce, A., Bond, K., Vreman, R. A., Largeron, N., Banhazi, J., Ollendorf, D. A., Jain, M., Upadhyaya, S., & Goettsch, W. G. (Accepted/In press). Lifecycle HTA: Promising applications and a framework for implementation. International Journal of Technology Assessment in Health Care, 1-25. https://doi.org/10.1017/S0266462324000187
Ooms, G. I., Usman, M. A., Reed, T., van den Ham, H. A., & Mantel-Teeuwisse, A. K. (2024). The impact of scheduling ketamine as an internationally controlled substance on anaesthesia care in Sub-Saharan Africa: a case study and key informant interviews. BMC Health Services Research, 24(1), Article 598. https://doi.org/10.1186/s12913-024-11040-w
Gini, R., Pajouheshnia, R., Gardarsdottir, H., Bennett, D., Li, L., Gulea, C., Wientzek-Fleischmann, A., Bazelier, M. T., Burcu, M., Dodd, C., Durán, C. E., Kaplan, S., Lanes, S., Marinier, K., Roberto, G., Soman, K., Zhou, X., Platt, R., Setoguchi, S., & Hall, G. C. (2024). Describing diversity of real world data sources in pharmacoepidemiologic studies: The DIVERSE scoping review. Pharmacoepidemiology and Drug Safety, 33(5), Article e5787. https://doi.org/10.1002/pds.5787
Schultze, A., Martin, I., Messina, D., Bots, S., Belitser, S., José Carreras-Martínez, J., Correcher-Martinez, E., Urchueguía-Fornes, A., Martín-Pérez, M., García-Poza, P., Villalobos, F., Pallejà-Millán, M., Alberto Bissacco, C., Segundo, E., Souverein, P., Riefolo, F., Durán, C. E., Gini, R., Sturkenboom, M., ... Douglas, I. (2024). A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases. Vaccine, 42(12), 3039-3048. https://doi.org/10.1016/j.vaccine.2024.03.043
Li, W., Sparidans, R. W., Wang, Y., Martins, M. L. F., de Waart, D. R., van Tellingen, O., Song, J.-Y., Lebre, M. C., van Hoppe, S., Wagenaar, E., Beijnen, J. H., & Schinkel, A. H. (2024). Interplay of OATP1A/1B/2B1 uptake transporters and ABCB1 and ABCG2 efflux transporters in the handling of bilirubin and drugs. Biomedicine and Pharmacotherapy, 175, Article 116644. Advance online publication. https://doi.org/10.1016/j.biopha.2024.116644
Coppes, T., Philbert, D., van Gelder, T., Bouvy, M. L., & Koster, E. S. (2024). Medication management during sick days: No differences between patients with and without impaired renal function. European Journal of Clinical Investigation, Article e14231. Advance online publication. https://doi.org/10.1111/eci.14231
van Nuland, M., Erdogan, A., Aςar, C., Contrucci, R., Hilbrants, S., Maanach, L., Egberts, T., & van der Linden, P. D. (2024). Performance of ChatGPT on Factual Knowledge Questions Regarding Clinical Pharmacy. Journal of Clinical Pharmacology. Advance online publication. https://doi.org/10.1002/jcph.2443
Kalf, R. (2024). Improving patient access to valuable new pharmaceuticals: Working towards and evidence ecosystem in healthcare. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/2182
Dutch Multiuse Dis Modeling (2024). A Blueprint for Multi-use Disease Modeling in Health Economics: Results from Two Expert-Panel Consultations. PharmacoEconomics. Advance online publication. https://doi.org/10.1007/s40273-024-01376-w
Loos, N. H. C. (2024). Relevance of pharmacological boosters in the disposition of oral anticancer drugs: Mouse models. [Doctoral thesis 2 (Research NOT UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/2190
van Nuland, M., Snoep, J. J. D., Egberts, T., Erdogan, A., Wassink, R., & van der Linden, P. D. (2024). Poor performance of ChatGPT in clinical rule-guided dose interventions in hospitalized patients with renal dysfunction. European Journal of Clinical Pharmacology. Advance online publication. https://doi.org/10.1007/s00228-024-03687-5
Manson, L. E. N., Nijenhuis, M., Soree, B., de Boer-Veger, N. J., Buunk, A. M., Houwink, E. J. F., Risselada, A., Rongen, G. A. P. J. M., van Schaik, R. H. N., Swen, J. J., Touw, D. J., van Westrhenen, R., Deneer, V. H. M., & Guchelaar, H. J. (2024). Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2C9, HLA-A and HLA-B with anti-epileptic drugs. European Journal of Human Genetics. Advance online publication. https://doi.org/10.1038/s41431-024-01572-4
Raethke, M., van Hunsel, F., Luxi, N., Lieber, T., Bellitto, C., Mulder, E., Ciccimarra, F., Riefolo, F., Thurin, N. H., Roy, D., Morton, K., Villalobos, F., Batel Marques, F., Farcas, A., Sonderlichová, S., Belitser, S., Klungel, O., Trifirò, G., & Sturkenboom, M. C. (2024). Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study. Vaccine, 42(9), 2357-2369. https://doi.org/10.1016/j.vaccine.2024.03.001
Verweij, S., Haverhoek, V., Bergman, E., Westman, G., & Bloem, L. T. (2024). A Natural Language Processing Approach towards Harmonized Communication of Uncertainties Identified during the European Medicine Authorization Process. Clinical Pharmacology and Therapeutics, 115(4), 871-880. https://doi.org/10.1002/cpt.3195
Schackmann, L., Koster, E. S., van Dijk, L., Vervloet, M., & Heringa, M. (2024). Communication skills-based training about medication switch encounters: pharmacy staff and patients’ experiences. International Journal of Clinical Pharmacy, 46(2), 439-450. https://doi.org/10.1007/s11096-023-01664-z
Werkman, N. C. C., García-Sáez, G., Nielen, J. T. H., Tapia-Galisteo, J., Somolinos-Simón, F. J., Hernando, M. E., Wang, J., Jiu, L., Goettsch, W. G., van der Kallen, C. J. H., Koster, A., Schalkwijk, C. G., de Vries, H., de Vries, N. K., Eussen, S. J. P. M., Driessen, J. H. M., & Stehouwer, C. D. A. (2024). Disease severity-based subgrouping of type 2 diabetes does not parallel differences in quality of life: the Maastricht Study. Diabetologia, 67(4), 690-702. https://doi.org/10.1007/s00125-023-06082-4
Loos, N. H. C., Sparidans, R. W., Heydari, P., Bui, V., Lebre, M. C., Beijnen, J. H., & Schinkel, A. H. (2024). The ABCB1 and ABCG2 efflux transporters limit brain disposition of the SYK inhibitors entospletinib and lanraplenib. Toxicology and Applied Pharmacology, 485, Article 116911. https://doi.org/10.1016/j.taap.2024.116911
Lalmohamed, A., Venekamp, R. P., Bolhuis, A., Souverein, P. C., van de Wijgert, J. H. H. M., Gulliford, M. C., & Hay, A. D. (2024). Within-episode repeat antibiotic prescriptions in patients with respiratory tract infections: A population-based cohort study. The Journal of Infection, 88(4), Article 106135. https://doi.org/10.1016/j.jinf.2024.106135
Jiu, L. (2024). Innovating Health Technology Assessment Methods: Barriers and Enablers illustrated using Qualitative and Quantitative Methods on Real-World Data. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/1310
Eroglu, T. E., Coronel, R., & Souverein, P. C. (2024). Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study. European heart journal. Cardiovascular pharmacotherapy. Advance online publication. https://doi.org/10.1093/ehjcvp/pvae022
Madrid Paredes, J., Versteeg, J.-W., Vreman, R. A., & Bloem, L. T. (2024). Agreement about Availability of Alternative Treatments for Innovative Drugs Assessed by the EMA and HTA Organizations. Clinical Pharmacology and Therapeutics. Advance online publication. https://doi.org/10.1002/cpt.3252
Metselaar-Albers, M., Meijerman, I., Engels, F., Haanen, J., Beijnen, J., & Lalmohamed, A. (2024). No detrimental association between antibiotic use and immune checkpoint inhibitor therapy: an observational cohort study comparing patients with ICI-treated and TKI-treated melanoma and NSCLC. Journal for ImmunoTherapy of Cancer, 12(1), Article e008269. https://doi.org/10.1136/jitc-2023-008269
van Paassen, J., Tan, J., Deneer, V., & Bouvy, M. (2024). Exploring the pharmacists' role in optimising antithrombotic therapy in primary care: a qualitative study. BMJ Open, 14(3), Article e079018. https://doi.org/10.1136/bmjopen-2023-079018
Jacobs, T. G., Okemo, D., Ssebagereka, A., Mwehonge, K., Njuguna, E. M., Burger, D. M., Colbers, A., Suleman, F., Mantel-Teeuwisse, A. K., & Ooms, G. I. (2024). Availability and stock-outs of paediatric antiretroviral treatment formulations at health facilities in Kenya and Uganda. HIV Medicine. Advance online publication. https://doi.org/10.1111/hiv.13635
Davies, L. E. M., Jansen-Groot Koerkamp, E. A. W., Koster, E. S., Dalusong, K.-J., Koch, B., Schellekens, A., Heringa, M., & Bouvy, M. (2024). Patient perspectives on primary care providers role in long-term opioid therapy. British Journal of General Practice. Advance online publication. https://doi.org/10.3399/BJGP.2023.0547
Shea, B., Pardo, J. P., Grosskleg, S., Beaton, D. E., Conaghan, P., Goettsch, W., Hofstetter, C., Maxwell, L., Musaus, J., Ollendorf, D., Schultz, G., Stevens, R., Strand, V., Tugwell, P., Williamson, P., Tunis, S., & Simon, L. S. (2024). Increasing uptake through collaboration in the development of core outcome sets: Lessons learned at OMERACT 2023. Seminars in Arthritis and Rheumatism, 66, Article 152438. Advance online publication. https://doi.org/10.1016/j.semarthrit.2024.152438
van Gelder, T. G., van Diem-Zaal, I. J., Dijkstra-Kersten, S. M. A., de Mul, N., Lalmohamed, A., & Slooter, A. J. C. (2024). The risk of delirium after sedation with propofol or midazolam in intensive care unit patients. British Journal of Clinical Pharmacology. Advance online publication. https://doi.org/10.1111/bcp.16031
Eroglu, TE., Coronel, R., & Gislason, GH. (2024). Use of proton pump inhibitors is associated with increased risk of out-of-hospital cardiac arrest in the general population: a nested case-control study. European Heart Journal - Cardiovascular Pharmacotherapy. Advance online publication. https://doi.org/10.1093/ehjcvp/pvae020
Schoegje, T., Hardman, L., De Vries, A., & Pieters, T. (2024). Improving expert search effectiveness: Comparing ways to rank and present search results. In CHIIR 2024 - Proceedings of the 2024 Conference on Human Information Interaction and Retrieval (pp. 56-65). (CHIIR 2024 - Proceedings of the 2024 Conference on Human Information Interaction and Retrieval). Association for Computing Machinery. https://doi.org/10.1145/3627508.3638296
Loos, NHC., Bui, V., de Jong, DH., Lebre, MC., Rosing, H., Beijnen, JH., & Schinkel, AH. (2024). Impact of loperamide on the pharmacokinetics and tissue disposition of ritonavir-boosted oral docetaxel therapy; a preclinical assessment. Cancer Chemotherapy and Pharmacology. Advance online publication. https://doi.org/10.1007/s00280-024-04662-8
van den Broek, W. W. A., Gimbel, M. E., Hermanides, R. S., Runnett, C., Storey, R. F., Knaapen, P., Emans, M. E., Oemrawsingh, R. M., Cooke, J., Galasko, G., Walhout, R., Stoel, M. G., von Birgelen, C., van Bergen, P. F. M. M., Brinckman, S. L., Aksoy, I., Liem, A., van't Hof, A. W. J., Jukema, J. W., ... ten Berg, J. M. (2024). The impact of patient-reported frailty on cardiovascular outcomes in elderly patients after non-ST-acute coronary syndrome. International Journal of Cardiology, 405, Article 131940. Advance online publication. https://doi.org/10.1016/j.ijcard.2024.131940
den Hartog, I., Zwep, LB., Meulman, JJ., Hankemeier, T., van de Garde, EMW., & van Hasselt, JGC. (2024). Longitudinal metabolite profiling of <i>Streptococcus pneumoniae</i>-associated community-acquired pneumonia. Metabolomics, 20(2), Article 35. https://doi.org/10.1007/s11306-024-02091-5
Van Gelder, T. G., Lalmohamed, A., Dorst-Mooiman, K. D., Dekker, J. C., Schinkel, M. J., Sikma, M. A., Uijtendaal, E. V., Kemper, M. M., & Egberts, T. C. G. (2024). Significante daling in verspilling RTA-spuiten. Pharmaceutisch Weekblad, 159(9), 15-17. https://www.pw.nl/achtergrond/2024/significante-daling-in-verspilling-rta-spuiten
Dankers, M., Hek, K., Mantel-Teeuwisse, A. K., van Dijk, L., & Nelissen-Vrancken, M. H. J. M. G. (2024). Adoption of new medicines in primary care: A comparison between the uptake of new oral anticoagulants and diabetes medicines. British Journal of Clinical Pharmacology, 90(3), 819-827. https://doi.org/10.1111/bcp.15959
Jiu, L., Wang, J., Javier Somolinos-Simón, F., Tapia-Galisteo, J., García-Sáez, G., Hernando, M., Li, X., Vreman, R. A., Mantel-Teeuwisse, A. K., & Goettsch, W. G. (2024). A literature review of quality assessment and applicability to HTA of risk prediction models of coronary heart disease in patients with diabetes. Diabetes Research and Clinical Practice, 209, Article 111574. https://doi.org/10.1016/j.diabres.2024.111574
Desmet, T., Julian, E., Van Dyck, W., Huys, I., Simoens, S., Giuliani, R., Toumi, M., Dierks, C., Dierks, J., Cardone, A., Houÿez, F., Pavlovic, M., Berntgen, M., Mol, P., Schiel, A., Goettsch, W., Gianfrate, F., Capri, S., Ryan, J., ... Ruof, J. (2024). An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators. Journal of market access & health policy, 12(1), 21-34. https://doi.org/10.3390/jmahp12010004
Rasmussen, N. H., Driessen, J. H. M., Kvist, A. V., Souverein, P. C., van den Bergh, J. P., & Vestergaard, P. (2024). Fracture patterns and associated risk factors in pediatric and early adulthood type 1 diabetes: Findings from a nationwide retrospective cohort study. Bone, 180, 1-9. Article 116997. https://doi.org/10.1016/j.bone.2023.116997
Joosse, I. R., Mantel-Teeuwisse, A. K., Suleman, F., & van den Ham, H. A. (2024). Monitoring Access to Child Medicines: Introducing a Standardized Set of Age-Appropriate Medicines. Children, 11(3), Article 266. https://doi.org/10.3390/children11030266
Trials@Home Consortium (2024). Opportunities and challenges for decentralized clinical trial approaches: European health technology assessment perspective. Value in Health, 27(3), 294-300. https://doi.org/10.1016/j.jval.2023.11.006
Verschueren, M. V., Peters, B. J., Bloem, L. T., Kruik, V. R., Uitvlugt, E. B., Bijsmans, A. R., Egberts, A. C., & van de Garde, E. M. (2024). Pembrolizumab Plus Chemotherapy Per PD-L1 Stratum In Patients With Metastatic Non-Small Cell Lung Cancer: Real-World Effectiveness Versus Trial Efficacy. Clinical Lung Cancer, 25(2), 119-127.e1. https://doi.org/10.1016/j.cllc.2023.12.011
Molewijk, E., Fliers, E., Dreijerink, K., van Dooren, A., & Heerdink, R. (2024). Quality of life, daily functioning, and symptoms in hypothyroid patients on thyroid replacement therapy: A Dutch survey. Journal of Clinical and Translational Endocrinology, 35, 1-10. Article 100330. https://doi.org/10.1016/j.jcte.2024.100330
Rijt-Weetink, Y. R. J. V., Egberts, T. C. G., Hunsel, F. P. A. M. V., Lewis, D. J., Yates, L. M., Winterfeld, U., & Puijenbroek, E. P. V. (2024). Validation of a Novel Method to Assess the Clinical Quality of Information in Pregnancy-Related Pharmacovigilance Case Reports: A ConcePTION Project. Drug Safety, 47(3), 261-270. https://doi.org/10.1007/s40264-023-01389-y
Abraham, K., Kvamme, I., Magrin Sammut, S., de Vries, S., Formosa, T., Dupree, R., Corro Ramos, I., Goettsch, W., & Franken, M. (2024). A blueprint for health technology assessment capacity building: lessons learned from Malta. International Journal of Technology Assessment in Health Care, 40(1), Article e11. https://doi.org/10.1017/S0266462324000072
Brinkhuis, F., Goettsch, W. G., Mantel - Teeuwisse, A., & Bloem, L. T. (2024). High cost oncology drugs without proof of added benefit are burdening health systems. The BMJ, 384, Article q511. https://doi.org/10.1136/bmj.q511
Loos, NHC., Martins, MLF., Rijmers, J., de Jong, D., Lebre, MC., Tibben, M., Beijnen, JH., & Schinkel, AH. (2024). Interplay of Ritonavir-Boosted Oral Cabazitaxel with the Organic Anion-Transporting Polypeptide (OATP) Uptake Transporters and Carboxylesterase 1 in Mice. Molecular pharmaceutics, 21(4), 1952-1964. https://doi.org/10.1021/acs.molpharmaceut.3c01205
Joosse, I. R., van den Ham, H. A., Mantel-Teeuwisse, A. K., & Suleman, F. (2024). The caregiver’s experience of childhood cancer treatment in South Africa. Journal of Pharmaceutical Policy and Practice, 17(1), Article 2312382. https://doi.org/10.1080/20523211.2024.2312382
Brinkhuis, F., Goettsch, W. G., Mantel - Teeuwisse, A., & Bloem, L. T. (2024). Added benefit and revenues of oncology drugs approved by the European Medicines Agency between 1995 and 2020: retrospective cohort study. The BMJ, 384, Article e077391. https://doi.org/10.1136/bmj-2023-077391
Bouwman, L., Sepodes, B., Leufkens, H., & Torre, C. (2024). Trends in orphan medicinal products approvals in the European Union between 2010–2022. Orphanet Journal of Rare Diseases, 19(1), Article 91. https://doi.org/10.1186/s13023-024-03095-z
Lelie-van der Zande, R., Teichert, M., & Bouvy, M. (2024). Rol voor openbaar apotheker als behandelaar bij recidiverende blaasontsteking? Huisarts en Wetenschap, 67(3), 33-35. https://doi.org/10.1007/s12445-024-2754-9
Annema, P. A., Derijks, H. J., Bouvy, M. L., & van Marum, R. J. (2024). Impact of Drug Recalls on Patients in The Netherlands: A 5-Year Retrospective Data Analysis. Clinical Pharmacology and Therapeutics, 115(6), 1365-1371. Advance online publication. https://doi.org/10.1002/cpt.3220
Jansen, M. S., Dekkers, O. M., le Cessie, S., Hooft, L., Gardarsdottir, H., de Boer, A., & Groenwold, R. H. H. (2024). Real-World Evidence to Inform Regulatory Decision Making: A Scoping Review. Clinical Pharmacology and Therapeutics, 115(6), 1269-1276. Advance online publication. https://doi.org/10.1002/cpt.3218
Jiu, L., Hartog, M., Wang, J., Vreman, R. A., Klungel, O. H., Mantel-Teeuwisse, A. K., & Goettsch, W. G. (2024). Tools for assessing quality of studies investigating health interventions using real-world data: a literature review and content analysis. BMJ Open, 14(2), Article e075173. https://doi.org/10.1136/bmjopen-2023-075173
Knikman, JE., Lopez-Yurda, M., Meulendijks, D., Schellens, JHM., Beijnen, J., Cats, A., & Guchelaar, HJ. (2024). A Nomogram to Predict Severe Toxicity in DPYD Wild-Type Patients Treated With Capecitabine-Based Anticancer Regimens. Clinical Pharmacology & Therapeutics, 115(2), 269-277. https://doi.org/10.1002/cpt.3100
Lin, L., Barkman, HJ., Smit, EF., de Langen, AJ., Steeghs, N., Beijnen, JH., & Huitema, ADR. (2024). Clinical Relevance of High Plasma Trough Levels of the Kinase Inhibitors Crizotinib, Alectinib, Osimertinib, Dabrafenib, and Trametinib in NSCLC Patients. Therapeutic Drug Monitoring, 46(1), 73-79. https://doi.org/10.1097/FTD.0000000000001120
Mertens, J. F., Kempen, T. G. H., Koster, E. S., Deneer, V. H. M., Bouvy, M. L., & van Gelder, T. (2024). Cognitive processes in pharmacists’ clinical decision-making. Research in Social and Administrative Pharmacy, 20(2), 105-114. https://doi.org/10.1016/j.sapharm.2023.10.007
Rasmussen, N. H., Driessen, J. H. M., Kvist, A. V., Souverein, P. C., van den Bergh, J., & Vestergaard, P. (2024). Fracture patterns in adult onset type 1 diabetes and associated risk factors - A nationwide cohort study. Bone, 179, 1-10. Article 116977. https://doi.org/10.1016/j.bone.2023.116977
van der Heijden, L. T., Ribbers, C. A., Vermunt, M. A. C., Pluim, D., Acda, M., Tibben, M., Rosing, H., Douma, J. A. J., Naipal, K., Bergman, A. M., Beijnen, J. H., Huitema, A. D. R., & Opdam, F. L. (2024). Is Higher Docetaxel Clearance in Prostate Cancer Patients Explained by Higher CYP3A? An In Vivo Phenotyping Study with Midazolam. Journal of Clinical Pharmacology, 64(2), 155-163. https://doi.org/10.1002/jcph.2362
Minjon, L. (2024). Monitoring antipsychotica bij jongeren kan veel beter. Pharmaceutisch Weekblad, 159(7), 12-14. https://www.pw.nl/achtergrond/2024/monitoring-antipsychotica-bij-jongeren-kan-veel-beter
Mertens, J., Koster, E., Deneer, V., Kempen, T., Bouvy, M., & van Gelder, T. (2024). 'MEER FOCUS OP KLINISCHE BESLUITVORMING IN ONDERWIJS'. Pharmaceutisch Weekblad, 159(4), 14-16.
Loos, NHC., Martins, MLF., de Jong, D., Lebre, MC., Tibben, M., Beijnen, JH., & Schinkel, A. H. (2024). Coadministration of ABCB1/P-glycoprotein inhibitor elacridar improves tissue distribution of ritonavir-boosted oral cabazitaxel in mice. International Journal of Pharmaceutics, 650, 1-13. Article 123708. https://doi.org/10.1016/j.ijpharm.2023.123708
Buhl, C., Jacobsen, R., Almarsdóttir, A. B., Abtahi, S., Andersen, A., Deligianni, E., Dermiki-Gkana, F., Kontogiorgis, C., Oikonomou, C., Kursite, M., Poplavska, E., Hegger, I., Goot, M. V. D., Ferreira, P. B. S., Ribeiro-Vaz, I., Silva, A. M., Kos, M., Lipovec, N. Č., Vliet, E. V., & Alves, T. L. (2024). Public's perspective on COVID-19 adenovirus vector vaccines after thrombosis with thrombocytopenia syndrome (TTS) reports and associated regulatory actions: A cross-sectional study in six EU member states. Vaccine, 42(3), 556-563. https://doi.org/10.1016/j.vaccine.2023.12.065
Narsai, K., Masekela, F. B., Leufkens, H. G. M., & Mantel-Teeuwisse, A. K. (2024). Outer packaging labelling of medicines in Southern African Development Community (SADC) countries: comparative analysis of requirements and transition terms for harmonisation. BMC Health Services Research, 24(1), Article 111. https://doi.org/10.1186/s12913-024-10585-0
van Veelen, A., Veerman, G. D. M., Verschueren, M. V., Gulikers, J. L., Steendam, C. M. J., Brouns, A. J. W. M., Dursun, S., Paats, M. S., Tjan-Heijnen, V. C. G., van der Leest, C., Dingemans, A. M. C., Mathijssen, R. H. J., van de Garde, E. M. W., Souverein, P., Driessen, J. H. M., Hendriks, L. E. L., van Geel, R. M. J. M., & Croes, S. (2024). Exploring the impact of patient-specific clinical features on osimertinib effectiveness in a real-world cohort of patients with EGFR mutated non-small cell lung cancer. International Journal of Cancer, 154(2), 332-342. https://doi.org/10.1002/ijc.34742
Trials@Home Consortium, van Rijssel, T. I., van Thiel, G. J. M. W., Gardarsdottir, H., & van Delden, J. J. M. (2024). Which Benefits Can Justify Risks in Research? American Journal of Bioethics, 1-11. Advance online publication. https://doi.org/10.1080/15265161.2023.2296404
Abdullah-Koolmees, H., Mekel, V. C. C., I Veldkamp, A., Caris, M. G., & Swart, E. L. (2024). A case report: Management of carbamazepine intoxication using hemodialysis followed by continuous venovenous hemodialysis. SAGE Open Medical Case Reports, 12, 1-5. https://doi.org/10.1177/2050313X241229844
Retmana, I. A., Çelebi, N., Rijmers, J., Schinkel, A. H., Beijnen, J. H., & Sparidans, R. W. (2024). Development and validation of an LC-MS/MS method for the quantification of KRASG12C inhibitor opnurasib in several mouse matrices and its application in a pharmacokinetic mouse study. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 1232, 1-11. Article 123964. https://doi.org/10.1016/j.jchromb.2023.123964
Costa, E., Moja, L., Wirtz, V. J., van den Ham, H. A., Huttner, B., Magrini, N., & Leufkens, H. G. (2024). Uptake of orphan drugs in the WHO essential medicines lists. Bulletin of the World Health Organization, 102(1), 22-31. https://doi.org/10.2471/BLT.23.289731
Zhang, P., Kuil, LE., Buil, LCM., Freriks, S., Beijnen, JH., van Tellingen, O., & de Gooijer, MC. (2024). Acquired and intrinsic resistance to vemurafenib in BRAFV600E-driven melanoma brain metastases. FEBS Open Bio, 14(1), 96-111. https://doi.org/10.1002/2211-5463.13730
Lu, Z., Fu, LW., Huang, LX., Ke, WJ., Leng, XY., Li, YW., Lin, YF., Marra, CM., Tian, T., Wang, JF., Wang, LY., Weng, WJ., Wu, JX., Wu, XS., Yang, B., Yang, LG., Yang, LY., Zhang, XH., Zhou, XY., & Zou, HC. (2024). Development, validation and clinical utility of a suite of simplified clinical diagnostic models for neurosyphilis based on multiple guidelines. Sexually Transmitted Diseases, 51(1), S400-S401. https://doi.org/10.1097/OLQ.0000000000001886
Manson, L., Nijenhuis, M., Soree, B., de Boer-Veger, N., Buunk, AM., Houwink, E., Risselada, A., Rongen, G., Van Schaik, R., Swen, J., Touw, D., Van der Weide, J., van Westrhenen, R., Deneer, V., & Guchelaar, HJ. (2024). EJHG series: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C9 and HLA and anti-epileptic drugs. European Journal of Human Genetics, 32, 683-683. https://doi.org/10.1038/s41431-023-01482-x
Aakjær, M., De Bruin, M. L., & Andersen, M. (2024). Epidemiological surveillance of drug safety using cumulative sequential analysis in electronic healthcare data. Basic and Clinical Pharmacology and Toxicology, 134(1), 129-140. https://doi.org/10.1111/bcpt.13955
Damoiseaux, D., Schinkel, A. H., Beijnen, J. H., Huitema, A. D. R., & Dorlo, T. P. C. (2024). Predictability of human exposure by human-CYP3A4-transgenic mouse models: A meta-analysis. Clinical and Translational Science, 17(1), Article e13668. https://doi.org/10.1111/cts.13668
ROAD Study Group (2024). Cost Savings and Waste Reduction Through Redispensing Unused Oral Anticancer Drugs: The ROAD Study. JAMA Oncology, 10(1), 87-94. https://doi.org/10.1001/jamaoncol.2023.4865
Beunk, L., Nijenhuis, M., Soree, B., de Boer-Veger, N. J., Buunk, A.-M., Guchelaar, H. J., Houwink, E. J. F., Risselada, A., Rongen, G. A. P. J. M., van Schaik, R. H. N., Swen, J. J., Touw, D., van Westrhenen, R., Deneer, V. H. M., & van der Weide, J. (2024). Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics. European Journal of Human Genetics, 32(3), 278–285. https://doi.org/10.1038/s41431-023-01347-3
van der Pol, K. H., Nijenhuis, M., Soree, B., de Boer-Veger, N. J., Buunk, A. M., Guchelaar, H.-J., Risselada, A., van Schaik, R. H. N., Swen, J. J., Touw, D., van der Weide, J., van Westrhenen, R., Deneer, V. H. M., Houwink, E. J. F., & Rongen, G. A. (2024). Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate. European Journal of Human Genetics, 32(2), 155-162. https://doi.org/10.1038/s41431-022-01180-0
Petro, E., Perumal-Pillay, V., Mantel-Teeuwisse, A. K., van den Ham, H. A., & Suleman, F. (2024). Evaluation of alignment of the reimbursement medicines list for children in Albania with the WHO essential medicines list for children. Journal of Pharmaceutical Policy and Practice, 17(1), 1-18. Article 2290100. https://doi.org/10.1080/20523211.2023.2290100
Kaló, Z., Niewada, M., Bereczky, T., Goettsch, W., Vreman, R. A., Xoxi, E., Trusheim, M., Callenbach, M. H. E., Nagy, L., & Simoens, S. (2024). Importance of aligning the implementation of new payment models for innovative pharmaceuticals in European countries. Expert Review of Pharmacoeconomics and Outcomes Research, 24(2), 181-187. https://doi.org/10.1080/14737167.2023.2282680
Hogervorst, M. A., Vreman, R., Heikkinen, I., & Oortwijn, W. (2024). Response to uncertainty management in regulatory and health technology assessment decision-making on drugs: Guidance of the HTAi-DIA Working Group - Author's reply. International Journal of Technology Assessment in Health Care, 40(1), 1-2. Article e1. https://doi.org/10.1017/S0266462323002817
van Dommelen, J. E. M., Grootjans, H., Uijtendaal, E. V., Ruigrok, D., Luijk, B., van Luin, M., Bult, W., de Lange, D. W., Kusadasi, N., Droogh, J. M., Egberts, T. C. G., Verschuuren, E. A. M., & Sikma, M. A. (2024). Tacrolimus Variability and Clinical Outcomes in the Early Post-lung Transplantation Period: Oral Versus Continuous Intravenous Administration. Clinical Pharmacokinetics, 63, 683-693. https://doi.org/10.1007/s40262-024-01368-1

2023

Dankers, M., Verlegh, P., Weber, K., Nelissen-Vrancken, M. H. J. M. G., van Dijk, L., & Mantel - Teeuwisse, A. (2023). Wat kunt u doen om ... niet beinvloed te worden? Nederlands Tijdschrift voor Geneeskunde, 167, Article D79997. https://www.ntvg.nl/artikelen/wat-kunt-u-doen-om-niet-beinvloed-te-worden
Tsai, D. H.-T., Bell, J. S., Abtahi, S., Baak, B. N., Bazelier, M. T., Brauer, R., Chan, A. Y. L., Chan, E. W., Chen, H., Chui, C. S. L., Cook, S., Crystal, S., Gandhi, P., Hartikainen, S., Ho, F. K., Hsu, S.-T., Ilomäki, J., Kim, J. H., Klungel, O. H., ... Lai, E. C.-C. (2023). Cross-Regional Data Initiative for the Assessment and Development of Treatment for Neurological and Mental Disorders. Clinical Epidemiology, 2023(15), 1241-1252. https://doi.org/10.2147/CLEP.S426485
Dankers, M., Verlegh, P. W. J., Weber, K., Nelissen-Vrancken, H. J. M. G. M., van Dijk, L., & Mantel-Teeuwisse, A. K. (2023). Wat kunt u doen om … niet beïnvloed te worden? Nederlands Tijdschrift voor Geneeskunde, 168, Article D7997.
Davies, L. E. M., Koster, E. S., Damen, K. F., Beurmanjer, H., van Dam, V. W., Bouvy, M. L., & Schellekens, A. F. (2023). Patients' perspectives on tapering programmes for prescription opioid use disorder: a qualitative study. BMJ Open, 13(12), 1-9. Article e075246. https://doi.org/10.1136/bmjopen-2023-075246
van Gelder, T. G., Lalmohamed, A., Dorst-Mooiman, K. D., Dekker, J. C., Schinkel, M. J., Sikma, M. A., Uijtendaal, E. V., & Egberts, T. C. G. (2023). Drug waste of ready-to-administer syringes in the intensive care unit: Aseptically prepared syringes versus prefilled sterilized syringes. European Journal of Pharmaceutical Sciences, 191, 1-7. Article 106590. https://doi.org/10.1016/j.ejps.2023.106590
Gort, J., van Hattem, C. C., Bloem, L. T., & ten Ham, R. M. T. (2023). Geneesmiddelen voor Geavanceerde Therapie (ATMP’s) in Nederland: Veldverkenning, Knelpuntanalyse en Activiteitenkaart. Utrecht University. https://doi.org/10.33540/1874/433501
Weesie, Y. M., van Dijk, L., Bouvy, M. L., & Hek, K. (2023). Immediate release fentanyl in general practices: Mostly off-label prescribing. European Journal of General Practice, 29(1), 1-7. Article 2165644. https://doi.org/10.1080/13814788.2023.2165644
Joosse, I. R., Tordrup, D., Glanville, J., Mantel-Teeuwisse, A. K., & van den Ham, H. A. (2023). A systematic review of policies regulating or removing mark-ups in the pharmaceutical supply and distribution chain. Health Policy, 138, 1-9. Article 104919. https://doi.org/10.1016/j.healthpol.2023.104919
Mfumbilwa, Z. A., Wilschut, J. A., Simons, M. J. H. G., Ramaekers, B., Joore, M., Retèl, V., der Welle, C. M. C., Schramel, F. M. N. H., van de Garde, E. M. W., & Coupé, V. M. H. (2023). Development and validation of a decision model for the evaluation of novel lung cancer treatments in the Netherlands. Scientific Reports, 13(1), Article 2349. https://doi.org/10.1038/s41598-023-29286-5
Trials@Home Consortium (2023). Direct-to-Participant Investigational Medicinal Product Supply in Clinical Trials in Europe - Exploring the Experiences of Sponsors, Site Staff, and Couriers. British Journal of Clinical Pharmacology, 89(12), 3512-3522. https://doi.org/10.1111/bcp.15850
Snijders, B. M. G., Kempen, T. G. H., Aubert, C. E., Koek, H. L., Dalleur, O., Donzé, J., Rodondi, N., O'Mahony, D., Gillespie, U., & Knol, W. (2023). Drug-related readmissions in older hospitalized adults: External validation and updating of OPERAM DRA prediction tool. Journal of the American Geriatrics Society, 71(12), 3848-3856. https://doi.org/10.1111/jgs.18575
Nijenhuis, M., Soree, B., Jama, W. O. M., de Boer-Veger, N. J., Buunk, A. M., Guchelaar, H.-J., Houwink, E. J. F., Rongen, G. A., van Schaik, R. H. N., Swen, J. J., Touw, D., van der Weide, J., van Westrhenen, R., Deneer, V. H. M., & Risselada, A. (2023). Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate. European Journal of Human Genetics, 31(12), 1364–1370. https://doi.org/10.1038/s41431-022-01262-z
Leopold, C., Poblete, S., & Vogler, S. (2023). How to Price and to Reimburse Publicly Funded Medicines in Latin America? Lessons Learned from Europe. Medicolegal news, 51(S1), 76-91. https://doi.org/10.1017/jme.2023.114
Ismail, R. K., Schramel, F. M. N. H., van Dartel, M., Pasmooij, A. M. G., Cramer-van der Welle, C. M., Hilarius, D. L., de Boer, A., Wouters, M. W. J. M., & van de Garde, E. M. W. (2023). Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from first-line immunotherapy in NSCLC. BMC Medical Research Methodology, 23(1), Article 1. https://doi.org/10.1186/s12874-022-01760-0
Grupstra, R. J., Goedecke, T., Scheffers, J., Strassmann, V., & Gardarsdottir, H. (2023). Review of Studies Evaluating Effectiveness of Risk Minimization Measures Assessed by the European Medicines Agency Between 2016 and 2021. Clinical Pharmacology and Therapeutics, 114(6), 1285-1292. https://doi.org/10.1002/cpt.3034
Pieters, T. (2023). The Imperative of Regulation: The Co-creation of a Medical and Non-medical US Opioid Crisis. Psychoactives, 2(4), 317–336. https://doi.org/10.3390/psychoactives2040020
van Moll, C., Egberts, T., Wagner, C., Zwaan, L., & Ten Berg, M. (2023). The Nature, Causes, and Clinical Impact of Errors in the Clinical Laboratory Testing Process Leading to Diagnostic Error: A Voluntary Incident Report Analysis. Journal of Patient Safety, 19(8), 573-579. https://doi.org/10.1097/PTS.0000000000001166
Lasys, T., Santa-Ana-Tellez, Y., Siiskonen, S. J., Groenwold, R. H. H., & Gardarsdottir, H. (2023). Unintended impact of pharmacovigilance regulatory interventions: A systematic review. British Journal of Clinical Pharmacology, 89(12), 3491-3502. https://doi.org/10.1111/bcp.15874
Riefolo, F., Castillo-Cano, B., Martín-Pérez, M., Messina, D., Elbers, R., Brink-Kwakkel, D., Villalobos, F., Ingrasciotta, Y., Garcia-Poza, P., Swart-Polinder, K., Souverein, P., Saiz, L. C., Bissacco, C. A., Leache, L., Tari, M., Crisafulli, S., Grimaldi, L., Vaz, T., Gini, R., ... Martín-Merino, E. (2023). Effectiveness of homologous/heterologous booster COVID-19 vaccination schedules against severe illness in general population and clinical subgroups in three European countries. Vaccine, 41(47), 7007-7018. https://doi.org/10.1016/j.vaccine.2023.10.011
Gan, C. (2023). Pharmacological and physiological roles of the carboxylesterase 1 enzyme complex. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/1980
Faber, W. R., Sewpersad, K., Menke, H., Avanzi, C., Geluk, A., & Pieters, T. (2023). Origin and spread of leprosy in Suriname. A historical and biomedical study. Frontiers in Tropical Diseases, 4, 1-10. Article 1258006. https://doi.org/10.3389/fitd.2023.1258006
Cam, H., Wennlöf, B., Gillespie, U., Franzon, K., Nielsen, E. I., Ling, M., Lindner, K.-J., Kempen, T. G. H., & Kälvemark Sporrong, S. (2023). The complexities of communication at hospital discharge of older patients: a qualitative study of healthcare professionals' views. BMC Health Services Research, 23(1), 1-18. Article 1211. https://doi.org/10.1186/s12913-023-10192-5
Retmana, I. A., Loos, N. H. C., Schinkel, A. H., Beijnen, J. H., & Sparidans, R. W. (2023). Development and validation of an HPLC-MS/MS method to quantify the KRAS inhibitor adagrasib in mouse plasma and tissue-related matrices. Biomedical Chromatography, 37(11), Article e5720. https://doi.org/10.1002/bmc.5720
Komen, J. J., Hunt, N. B., Pottegård, A., Hjemdahl, P., Wettermark, B., Olesen, M., Bennie, M., Mueller, T., Carragher, R., Karlstad, Ø., Kjerpeseth, L. J., Klungel, O. H., & Forslund, T. (2023). Heterogeneity after harmonisation: a retrospective cohort study of bleeding and stroke risk after the introduction of direct oral anticoagulants in four Western European countries. Pharmacoepidemiology and Drug Safety, 32(11), 1223-1232. https://doi.org/10.1002/pds.5650
la Roi-Teeuw, H. M., van Smeden, M., Geersing, G.-J., Klungel, O. H., Rutten, F. H., Souverein, P. C., & van Doorn, S. (2023). Incidence and individual risk prediction of post-COVID-19 cardiovascular disease in the general population: a multivariable prediction model development and validation study. European Heart Journal Open, 3(6), 1-12. Article oead101. https://doi.org/10.1093/ehjopen/oead101
van Hulten, V., Driessen, J. H. M., Starup-Linde, J. K., Al-Mashhadi, Z. K., Viggers, R., Klungel, O. H., Souverein, P. C., Vestergaard, P., Stehouwer, C. D. A., & van den Bergh, J. P. (2023). The associations of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors as add-on to metformin with fracture risk in patients with type 2 diabetes mellitus. Diabetes, Obesity & Metabolism, 25(11), 3235-3247. https://doi.org/10.1111/dom.15220
Horikx, A., & Pieters, T. (2023). Inmiddels is 56% van de Apothekers in Nederland vrouw. Pharmaceutisch Weekblad, 158(43), 14-16. https://www.pw.nl/achtergrond/2023/inmiddels-is-56-van-de-apothekers-in-nederland-vrouw
Hageman, S. H., Petitjean, C., Pennells, L., Kaptoge, S., Pajouheshnia, R., Tillmann, T., Blaha, M. J., McClelland, R. L., Matsushita, K., Nambi, V., Klungel, O. H., Souverein, P. C., van der Schouw, Y. T., Verschuren, W. M., Lehmann, N., Erbel, R., Jöckel, K.-H., Di Angelantonio, E., Visseren, F. L., & Dorresteijn, J. A. (2023). Improving 10-year cardiovascular risk prediction in apparently healthy people: flexible addition of risk modifiers on top of SCORE2. European Journal of Preventive Cardiology, 30(15), 1705-1714. https://doi.org/10.1093/eurjpc/zwad187
Retmana, I. A., Loos, N. H. C., Schinkel, A. H., Beijnen, J. H., & Sparidans, R. W. (2023). Validated LC-MS/MS method for simultaneous quantification of KRASG12C inhibitor sotorasib and its major circulating metabolite (M24) in mouse matrices and its application in a mouse pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis, 235, Article 115612. https://doi.org/10.1016/j.jpba.2023.115612
Meijboom, R. W. (2023). TNFα inhibitor treatment trajectories: learnings on biosimilars in clinical practice. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/1837
Pieters, T. (2023). Belangstelling tonen vonden patiënten altijd heel prettig. Uitsluitend voor Apothekersassistenten, 18-19.
Schene, M. R., Wyers, C. E., Driessen, A. M. H., Souverein, P. C., Gemmeke, M., Van Den Bergh, J. P., & Willems, H. C. (2023). Imminent fall risk after fracture. Age and Ageing, 52(10), Article afad201. https://doi.org/10.1093/ageing/afad201
Loos, N. H. C., Retmana, I. A., Rijmers, J., Wang, Y., Gan, C., Lebre, M. C., Sparidans, R. W., Beijnen, J. H., & Schinkel, A. H. (2023). Pharmacokinetics of the KRAS G12C inhibitor adagrasib is limited by CYP3A and ABCB1, and influenced by binding to mouse plasma carboxylesterase 1c. Biomedicine and Pharmacotherapy, 166, Article 115304. https://doi.org/10.1016/j.biopha.2023.115304
Oosten, W., Vos, E., Los, L., Nelwan, M., & Pieters, T. (2023). Towards a new dynamic interaction model of adolescent CUD manifestation, prevention and treatment: a narrative review. Psychoactives, 2 (4), 294–316. https://doi.org/10.3390/psychoactives2040019
Gulikers, J. L., van Veelen, A. J., Driessen, J. H. M., Souverein, P. C., Tjan-Heijnen, V. C. G., Hendriks, L. E. L., van Geel, R. M. J. M., & Croes, S. (2023). Comparison of characteristics of patients with lung cancer in U.K. primary care databases: Clinical Practice Research Datalink Aurum and GOLD. Pharmacoepidemiology and Drug Safety, 32(10), 1161-1177. https://doi.org/10.1002/pds.5637
Essink, S. C. M., Zomerdijk, I. M., Straus, S. M. J. M., Gardarsdottir, H., & De Bruin, M. L. (2023). Duration of Effectiveness Evaluation of Additional Risk Minimisation Measures for Centrally Authorised Medicinal Products in the EU Between 2012 and 2021. Drug Safety, 46(10), 1007-1020. https://doi.org/10.1007/s40264-023-01341-0
van Hattem, C. C., de Jong, A., de Groot, J. S., & Bloem, L. T. (2023). Feasibility of post-authorization randomized controlled trials for conditionally authorized anticancer medicines-A multistakeholder perspective. Pharmacoepidemiology and Drug Safety, 32, 623-623.
Alsamil, A. M., Gardarsdottir, H., Leufkens, H. G., Egberts, T. C., & Giezen, T. J. (2023). Post-approval quality-related regulatory actions for biopharmaceuticals approved in the European Union and the United States between 1995 and 2019. Drug Discovery Today, 28(10), Article 103725. https://doi.org/10.1016/j.drudis.2023.103725
Jansen-Groot Koerkamp, E. A. W., de Kleijn, L., Fakhry, R., Chiarotto, A., Heringa, M., Rijkels-Otters, H. J. B. M., Blom, J. W., Numans, M. E., Koes, B. W., & Bouvy, M. L. (2023). Pragmatic Delphi study aimed at determining practical components for a tool designed to assist Dutch primary care-givers in opioid deprescribing for non-cancer pain. Family Practice, 40(5-6), 827-843. https://doi.org/10.1093/fampra/cmad058
Hoogendoorn, M., Fabriek, B., & Bloem, L. T. (2023). Regulatory and health technology assessment of cell and gene therapies in Europe: Convergence or divergence? Pharmacoepidemiology and Drug Safety, 32, 16-16.
Eskola, S. M., Jokinen, S., Bloem, L. T., Brouwer, E., Brown, D. A., Camarero, J., De Bruin, M. L. L., Gardarsdottir, H., & Hakkarainen, K. M. (2023). Systematic review of externally controlled (EC) trials, data used in them, and their role in regulatory decision-making. Pharmacoepidemiology and Drug Safety, 32(supplement 1), 260-261. Article 260.
Hogervorst, S., Vervloet, M., Janssen, R., Koster, E., Adriaanse, M. C., Bekker, C. L., van den Bemt, B. J. F., Bouvy, M., Heerdink, E. R., Hugtenburg, J. G., van Woerkom, M., Zwikker, H., van de Steeg-van Gompel, C., & van Dijk, L. (2023). Implementing medication adherence interventions in four Dutch living labs; context matters. BMC Health Services Research, 23(1), 1-13. Article 1030. https://doi.org/10.1186/s12913-023-10018-4
Chahid, Y., Chahid, F., van de Garde, E., Booij, J., Verberne, H. J., & Hendrikse, N. H. (2023). CYP3A4 inhibitors do not influence [68Ga]Ga-DOTA-TATE uptake in liver tissue. EJNMMI Research, 13(1), Article 84. https://doi.org/10.1186/s13550-023-01034-w
Joosse, I. R., Van Den Ham, H. A., Mantel-Teeuwisse, A. K., & Suleman, F. (2023). Alignment in the registration, selection, procurement and reimbursement of essential medicines for childhood cancers in South Africa. BMJ Global Health, 8(9), Article e012309. https://doi.org/10.1136/bmjgh-2023-012309
Pieters, T., Meredith, A. L., & Braig, H. R. (2023). More on Autochthonous Leprosy in the United States. The New England journal of medicine, 389(10), 963-964. https://doi.org/10.1056/NEJMc2308758
Chahid, Y., Hashimi, K., van de Garde, E. M. W., Klümpen, H.-J., Hendrikse, N. H., Booij, J., & Verberne, H. J. (2023). The Influence of Long-Acting Somatostatin Analogs on 68 Ga-DOTATATE Uptake in Patients With Neuroendocrine Tumors. Clinical Nuclear Medicine, 48(9), 757-762. https://doi.org/10.1097/RLU.0000000000004776
van Brug, H. E., Nelissen, R. G. H. H., Rosendaal, F. R., van Dorp, E. L. A., Bouvy, M. L., Dahan, A., & Gademan, M. G. J. (2023). What Changes Have Occurred in Opioid Prescriptions and the Prescribers of Opioids Before TKA and THA? A Large National Registry Study. Clinical Orthopaedics and Related Research, 481(9), 1716-1728. https://doi.org/10.1097/CORR.0000000000002653
Hempenius, M., Bots, S. H., Groenwold, R. H. H., de Boer, A., Klungel, O. H., & Gardarsdottir, H. (2023). Bias in observational studies on the effectiveness of in hospital use of hydroxychloroquine in COVID-19. Pharmacoepidemiology and Drug Safety, 32(9), 1001-1011. https://doi.org/10.1002/pds.5632
Hulshof, E. C., Deenen, M. J., Nijenhuis, M., Soree, B., de Boer-Veger, N. J., Buunk, A.-M., Houwink, E. J. F., Risselada, A., Rongen, G. A. P. J. M., van Schaik, R. H. N., Touw, D. J., van der Weide, J., van Westrhenen, R., Deneer, V. H. M., Guchelaar, H.-J., & Swen, J. J. (2023). Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between UGT1A1 and irinotecan. European Journal of Human Genetics, 31(9), 1088-1089. https://doi.org/10.1038/s41431-023-01315-x
Hulshof, E. C., Deenen, M. J., Nijenhuis, M., Soree, B., de Boer-Veger, N. J., Buunk, A.-M., Houwink, E. J. F., Risselada, A., Rongen, G. A. P. J. M., van Schaik, R. H. N., Touw, D. J., van der Weide, J., van Westrhenen, R., Deneer, V. H. M., Guchelaar, H.-J., & Swen, J. J. (2023). Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction between UGT1A1 and irinotecan. European Journal of Human Genetics, 31(9), 982–987. https://doi.org/10.1038/s41431-022-01243-2
Mertens, J. F., Koster, E. S., Deneer, V. H. M., Bouvy, M. L., & van Gelder, T. (2023). Factors influencing pharmacists' clinical decision making in pharmacy practice. Research in Social and Administrative Pharmacy, 19(9), 1267-1277. https://doi.org/10.1016/j.sapharm.2023.05.009
Costa, E., Girotti, S., van den Ham, H. A., Cipolli, M., van der Ent, C. K., Taylor-Cousar, J. L., & Leufkens, H. G. M. (2023). Traits, trends and hits of orphan drug designations in cystic fibrosis. Journal of Cystic Fibrosis, 22(5), 949-957. https://doi.org/10.1016/j.jcf.2023.07.006
Hogervorst, M. A., Møllebæk, M., Vreman, R. A., Lu, T. A., Wang, J., De Bruin, M. L., Leufkens, H. G. M., Mantel-Teeuwisse, A., & Goettsch, W. (2023). Perspectives on how to build bridges between regulation, health technology assessment and clinical guideline development: a qualitative focus group study with European experts. BMJ Open, 13(8), Article e072309. https://doi.org/10.1136/bmjopen-2023-072309
den Uil, M. G., Hut, H. W., Wagelaar, K. R., Abdullah-Koolmees, H., Cahn, W., Wilting, I., & Deneer, V. H. M. (2023). Pharmacogenetics and phenoconversion: the influence on side effects experienced by psychiatric patients. Frontiers in Genetics, 14, Article 1249164. https://doi.org/10.3389/fgene.2023.1249164
Durán, C. E., Riera-Arnau, J., Abtahi, S., Pajouheshnia, R., Hoxhaj, V., Gamba, M., Alsina, E., Martin-Perez, M., Garcia-Poza, P., Llorente-Garcia, A., Gonzalez-Bermejo, D., Ibánez, L., Sabaté, M., Vidal, X., Ballarín, E., Sanfélix-Gimeno, G., Rodríguez-Bernal, C., Peiró, S., García-Sempere, A., ... Sturkenboom, M. (2023). Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis. Frontiers in Pharmacology, 14, Article 1207976. https://doi.org/10.3389/fphar.2023.1207976
Kempen, T. G. H., Koumi, R., & Sporrong, S. K. (2023). Pharmacists in general practice: what do they do? A qualitative case study. International Journal of Clinical Pharmacy, 45(6), 1472–1482. https://doi.org/10.1007/s11096-023-01619-4
Glans, M., Kempen, T. G. H., Jakobsson, U., Kragh Ekstam, A., Bondesson, Å., & Midlöv, P. (2023). Identifying older adults at increased risk of medication-related readmission to hospital within 30 days of discharge: development and validation of a risk assessment tool. BMJ Open, 13(8), Article e070559. https://doi.org/10.1136/bmjopen-2022-070559
Sindahl, P., Overgaard-Steensen, C., Wallach-Kildemoes, H., De Bruin, M. L., Kemp, K., & Gardarsdottir, H. (2023). Impact of a Treatment Guide on Intravenous Fluids in Minimising the Risk of Hospital-Acquired Hyponatraemia in Denmark. Journal of Clinical Medicine, 12(15), Article 5105. https://doi.org/10.3390/jcm12155105
Verschueren, M. V., Dijs, T., Gulikers, J. L., Veelen, A. V., Croes, S., Hendriks, L. E., Smit, A. A., Bloem, L. T., Egberts, A. C., van de Garde, E. M., & Peters, B. J. (2023). Durvalumab after chemoradiotherapy in patients with stage III non-small-cell lung cancer: real-world outcomes versus clinical trial results. Immunotherapy, 15(11), 839-851. https://doi.org/10.2217/imt-2023-0002
Joosse, I. R., Tordrup, D., Bero, L., Mantel-Teeuwisse, A. K., & van den Ham, H. A. (2023). A critical review of methodologies used in pharmaceutical pricing policy analyses. Health Policy, 134, Article 104576. https://doi.org/10.1016/j.healthpol.2022.03.003
Meijvis, V. A. M., Heringa, M., Kwint, H.-F., de Wit, N. J., & Bouvy, M. L. (2023). Barriers and facilitators for the implementation of the CombiConsultation by general practitioners, pharmacists and practice nurses: a qualitative interview study. International Journal of Clinical Pharmacy, 45(4), 970-979. https://doi.org/10.1007/s11096-023-01597-7
Ooms, G. I., van Oirschot, J., de Kant, D., van den Ham, H. A., Mantel-Teeuwisse, A. K., & Reed, T. (2023). Barriers to accessing internationally controlled essential medicines in sub-saharan Africa: A scoping review. International Journal of Drug Policy, 118, Article 104078. https://doi.org/10.1016/j.drugpo.2023.104078
Li, R., Shokri, F., Rincon, A. L., Rivadeneira, F., Medina-Gomez, C., & Ahmadizar, F. (2023). Bi-Directional Interactions between Glucose-Lowering Medications and Gut Microbiome in Patients with Type 2 Diabetes Mellitus: A Systematic Review. Genes, 14(8), Article 1572. https://doi.org/10.3390/genes14081572
Joosse, I. R., Tordrup, D., Glanville, J., Kotas, E., Mantel-Teeuwisse, A. K., & van den Ham, H. A. (2023). Evidence on the effectiveness of policies promoting price transparency -: A systematic review. Health Policy, 134, Article 104681. https://doi.org/10.1016/j.healthpol.2022.11.002
Dankers, M., Verlegh, P., Weber, K., Nelissen-Vrancken, M., van Dijk, L., & Mantel-Teeuwisse, A. (2023). Marketing of medicines in primary care: An analysis of direct marketing mailings and advertisements. PLoS One, 18(8 August), Article e0290603. https://doi.org/10.1371/journal.pone.0290603